Case Study: a European biotechnology company assesses US gene therapy commercial potential with GlobalData

European Biotechnology Company - Customer Case Study

A European biotechnology company engaged the consulting services of GlobalData to assess the commercial potential for a novel gene therapy it had in development for a cardiovascular condition. The client's primary challenge was to determine the product's viability and forecast its revenue potential specifically for the US market to support critical commercial decisions.

GlobalData's solution involved testing various clinical trial design scenarios and conducting in-depth primary and secondary research with physicians and payer advisors. The outcome was a comprehensive market report that provided the likelihood of approval, a customized product forecast for revenue and patient numbers, and eNPV calculations. This analysis directly supported the client's ongoing strategic decisions for US market entry and positioning.